HEALTH

Diabetes Treatment and Management: A Practical Medical Overview

Diabetes is a chronic condition in which blood glucose remains too high because the body does not produce enough insulin, cannot use insulin effectively, or experiences both problems. Over time, uncontrolled diabetes can damage blood vessels, nerves, kidneys, eyes, and other organs. The World Health Organization reports that 14% of adults worldwide were living with diabetes in 2022, up from 7% in 1990. It also estimates that 59% of adults aged 30 and older with diabetes were not receiving diabetes medication that year, with the largest treatment gaps in low- and middle-income countries.

DE
By Dr. Elena Park·Jul 23, 2026 · 80 min read
Key Takeaways
Diabetes treatment must be matched to the type of diabetes and the individual’s medical circumstances.
Type 1 diabetes requires daily insulin, while type 2 diabetes may be treated with lifestyle support, several medication classes, insulin, or a combination.
Treatment should protect the heart, kidneys, eyes, nerves, and feet rather than focus only on A1C.
Glucose targets should be individualized to balance long-term benefit with the risk of hypoglycemia and treatment burden.
CGM, insulin pumps, and automated delivery systems can support management but require training and backup planning.
Regular complication screening and preparation for illness are essential even when a person feels well.
Diabetes education, emotional support, affordability, and realistic daily routines are fundamental parts of effective care.

Modern diabetes treatment is not limited to lowering a glucose number. Effective care may also involve reducing the risk of heart attack, stroke, kidney disease, vision loss, nerve damage, severe hypoglycemia, and diabetic ketoacidosis. Treatment plans should account for the type of diabetes, age, pregnancy, kidney and heart health, risk of low blood glucose, medication access, lifestyle, personal priorities, and ability to manage the plan safely.

TheAmerican Diabetes Association’s 2026 Standards of Careemphasize evidence-based, person-centered treatment rather than one universal plan for everyone with diabetes.

This article provides general educational information. It is not a replacement for diagnosis, medication advice, or an individualized diabetes care plan from a qualified healthcare professional.

Diabetes Is Not One Disease

The main forms of diabetes differ in their underlying causes and treatment requirements.

Type 1 diabetes

Type 1 diabetes is an autoimmune condition in which the immune system destroys the pancreatic cells that produce insulin. People with type 1 diabetes make little or no insulin and need insulin every day to remain alive. It can develop at any age, although it is commonly diagnosed in children and younger adults.

Type 2 diabetes

Type 2 diabetes usually involves insulin resistance, meaning the body does not respond to insulin effectively. Over time, the pancreas may also become less able to produce sufficient insulin.

Treatment may include nutrition and physical-activity changes, weight management, oral or injectable medication, and insulin. The appropriate combination can change as the condition progresses or as other health problems develop.

Gestational diabetes

Gestational diabetes is first diagnosed during pregnancy. Treatment may include a structured eating plan, physical activity when medically appropriate, glucose monitoring, and insulin when lifestyle measures are insufficient. Pregnancy requires different glucose targets and medication-safety considerations from routine adult diabetes care.

Other, less common forms can result from genetic conditions, pancreatic disease, endocrine disorders, or certain medications. Correct classification matters because treatment that is appropriate for type 2 diabetes may be unsafe or ineffective for someone with another form.

The Main Goals of Diabetes Treatment

Successful diabetes management usually has several connected goals:

keeping glucose within an individualized target range;
avoiding frequent or severe hypoglycemia;
reducing symptoms of high glucose;
protecting the heart, blood vessels, kidneys, eyes, nerves, and feet;
supporting a sustainable eating and activity pattern;
reducing treatment burden where possible;
maintaining quality of life;
preparing for illness, travel, pregnancy, surgery, and other changes;
making treatment affordable and realistic.

TheNational Institute of Diabetes and Digestive and Kidney Diseasesuses the “diabetes ABCs” to connect glucose management with A1C, blood pressure, cholesterol, and smoking cessation. This reflects an important principle: diabetes treatment must address cardiovascular and organ health as well as glucose.

For many adults, an A1C level below 7% is a common general goal, but it is not appropriate for everyone. Targets may be adjusted according to age, pregnancy, duration of diabetes, other health conditions, life expectancy, medication burden, and the risk of severe low blood glucose.

How Treatment Differs by Diabetes Type

Treatment component Type 1 diabetes Type 2 diabetes

Insulin Essential every day May be temporary or long-term, depending on need

Oral medication Limited role in selected cases Common, with several medication classes available

Non-insulin injections Sometimes used as an additional treatment Frequently considered for glucose, weight, heart, or kidney goals

Glucose monitoring Usually frequent; CGM is often used Frequency depends on treatment, control, and hypoglycemia risk

Automated insulin delivery An option for many insulin users, especially with type 1 diabetes Available for selected insulin-treated patients

Weight management May support general health but does not replace insulin Can be a major part of treatment

Cardiovascular and kidney protection Important according to individual risk Often directly influences medication selection

Diabetes education Essential Essential

This table is a broad overview. Individual treatment decisions require professional assessment.

Diabetes Self-Management Education and Support

Most diabetes care takes place outside a clinic. People must make daily decisions about meals, activity, medicines, monitoring, illness, work, travel, and stress.

Diabetes self-management education and support can help people understand:

how their medication works;
how and when to measure glucose;
how meals and physical activity affect glucose;
how to recognize hypoglycemia;
what to do during illness;
how to use insulin safely;
how to inspect and protect their feet;
how to interpret glucose patterns;
when to contact a healthcare professional.

TheCDCdescribes healthy eating, physical activity, glucose monitoring, medication adherence, stress management, and regular checkups as core elements of living with diabetes. Education should be revisited when treatment changes, complications develop, technology is introduced, or a person encounters difficulties following the plan.

Nutrition and Physical Activity

There is no single mandatory “diabetes diet.” A useful eating pattern should support glucose management, cardiovascular health, nutritional adequacy, and the person’s cultural, financial, and practical circumstances.

Depending on individual needs, guidance may address:

portion size;
carbohydrate amount and timing;
fiber-rich foods;
vegetables, legumes, whole grains, and suitable protein sources;
saturated fat and sodium;
sugar-sweetened drinks;
meal timing around insulin or other medication;
food access and affordability.

TheCDC’s healthy-eating guidancerecommends working with a registered dietitian or diabetes educator to develop a sustainable plan rather than relying on special “diabetic” products or highly restrictive diets.

Physical activity may improve insulin sensitivity, glucose control, blood pressure, sleep, mood, mobility, and cardiovascular health. NIDDK generally recommends at least 150 minutes of moderate-intensity activity per week for many adults, together with muscle-strengthening activity when appropriate. However, safe activity levels may differ for people with cardiovascular disease, severe neuropathy, foot ulcers, advanced eye disease, recurrent hypoglycemia, or other complications.

Exercise is not a substitute for insulin in type 1 diabetes. Insulin, food intake, glucose trends, and activity may need to be coordinated to reduce the risk of hypoglycemia.

Insulin Treatment

Insulin in type 1 diabetes

Insulin replacement is the foundation of type 1 diabetes treatment.

Insulin can be delivered through:

syringes;
insulin pens;
wearable pumps;
automated insulin-delivery systems.

A treatment plan usually combines background insulin with additional insulin around meals and to correct high glucose. Exact doses and timing must be individualized according to glucose levels, food intake, activity, illness, and other factors.

Automated insulin-delivery systems combine a continuous glucose monitor, an insulin pump, and software that adjusts insulin delivery in response to glucose readings. These systems may reduce some of the burden of diabetes management, but users still need training, backup supplies, and a plan for sensor, pump, or infusion-site failure.

Insulin in type 2 diabetes

Some people with type 2 diabetes need insulin at diagnosis because glucose is very high or symptoms are severe. Others begin insulin later when non-insulin treatments no longer provide sufficient control.

Insulin may also be needed temporarily during serious illness, hospitalization, pregnancy, surgery, or treatment with medications that raise glucose. Using insulin does not mean that a person has “failed” to manage diabetes; type 2 diabetes can progress as insulin production declines.

The main risks include hypoglycemia and, with some regimens, weight gain. Treatment therefore requires education about dosing, meals, activity, monitoring, storage, and management of low glucose.

Medication Approaches for Type 2 Diabetes

Type 2 diabetes medicines work through different mechanisms. Some reduce glucose production by the liver, improve insulin sensitivity, stimulate insulin release, slow digestion, affect appetite, or cause the kidneys to remove more glucose through urine.

Metformin

Metformin remains a common initial medication. It reduces glucose production by the liver and improves the body’s response to insulin. However, it is no longer automatically the first or only choice for every patient. Kidney function, gastrointestinal effects, other conditions, treatment goals, and access must be considered.

GLP-1 receptor agonists and related therapies

GLP-1 receptor agonists can lower glucose, reduce appetite, and support weight loss in some people. Certain medications in this group have also demonstrated cardiovascular or kidney benefits in specific patient populations.

They are not substitutes for insulin in type 1 diabetes. Potential limitations include gastrointestinal side effects, cost, access, contraindications, and the need to follow product-specific instructions.

SGLT2 inhibitors

SGLT2 inhibitors cause the kidneys to remove more glucose through urine. For appropriate people with type 2 diabetes, chronic kidney disease, heart failure, or cardiovascular risk, current ADA guidance may prioritize an SGLT2 inhibitor because its benefits can extend beyond A1C reduction.

These medicines also have important risks, including dehydration, genital infections, and diabetic ketoacidosis in some circumstances. A person may need specific instructions for illness, fasting, or surgery.

Other medication classes

Other options include:

DPP-4 inhibitors;
sulfonylureas;
thiazolidinediones;
alpha-glucosidase inhibitors;
meglitinides;
insulin and insulin combinations.

Each class has a different balance of glucose-lowering effect, hypoglycemia risk, weight effect, cost, dosing burden, and suitability for people with heart, liver, or kidney conditions.

Medication should not be selected solely from an online list. TheFDA’s diabetes medicines resourcesemphasize discussing benefits, side effects, interactions, pregnancy, and other medical conditions with a healthcare professional.

Weight Management and Metabolic Surgery

For people with type 2 diabetes and overweight or obesity, weight management can be an important treatment component. Even when glucose improvement is the immediate goal, management should also consider blood pressure, liver health, mobility, sleep, cardiovascular risk, medication burden, and quality of life.

Approaches may include:

nutrition and activity support;
behavioral treatment;
weight-management medication;
metabolic or bariatric surgery for suitable candidates.

Metabolic surgery can substantially improve glucose control and may lead to diabetes remission in some people with type 2 diabetes. However, remission is not guaranteed or necessarily permanent. Long-term nutrition monitoring, medical follow-up, and complication screening may still be necessary.

Weight stigma can interfere with care. Treatment should focus on health, safety, informed choice, and sustainable support rather than blame.

Glucose Monitoring and Diabetes Technology

Blood glucose meters

A blood glucose meter measures glucose from a small blood sample at a particular moment. Monitoring frequency depends on the type of diabetes, medication, stability, hypoglycemia risk, illness, and treatment goals.

TheFDAadvises using approved meters and compatible test strips correctly. Contaminated fingers, expired strips, incorrect storage, dehydration, and device limitations can affect readings.

Continuous glucose monitoring

A continuous glucose monitor uses a sensor under the skin to estimate glucose in interstitial fluid and display trends throughout the day and night. Alerts may warn of predicted high or low levels.

CGM can provide more information than an occasional fingerstick, but readings may not always match blood glucose exactly. A meter may still be needed when symptoms do not match the sensor reading, the device reports an error, or the manufacturer’s instructions recommend confirmation.

Useful CGM measures may include:

time in range;
time below range;
time above range;
glucose variability;
overnight patterns.

For many people, the commonly used target range is 70–180 mg/dL, but both the range and the desired percentage of time within it should be individualized.

Technology is most effective when the person understands how to interpret the information and when the healthcare team reviews patterns rather than reacting to isolated readings.

Protecting the Heart and Kidneys

Cardiovascular disease is a major concern in diabetes. Treatment may involve managing blood pressure, cholesterol, smoking, physical activity, weight, and glucose.

Current guidelines increasingly select certain type 2 diabetes medicines partly for their demonstrated cardiovascular, heart-failure, or kidney benefits. This means that the medication producing the greatest A1C reduction is not automatically the best option for every person.

Kidney monitoring usually includes blood tests that estimate filtration and urine testing for albumin. Detecting kidney damage early can influence blood-pressure treatment, medication selection, dosing, and referral to a kidney specialist.

Kidney function also affects the safety and dosage of several diabetes medicines. Treatment should be reviewed as kidney function changes.

Screening for Long-Term Complications

Complications may progress before obvious symptoms appear. Regular screening is therefore a treatment tool, not merely a diagnostic formality.

Monitoring may include:

dilated eye examinations or retinal imaging;
kidney-function and urine-albumin tests;
foot and skin examinations;
assessment for nerve damage;
blood pressure and cholesterol measurement;
dental care;
cardiovascular risk review.

The ADA’s2026 guidance on retinopathy, neuropathy, and foot careemphasizes risk-based eye, nerve, and foot assessment. People with numbness, previous ulcers, poor circulation, foot deformity, or a history of amputation generally require more intensive foot care.

New foot wounds, discoloration, swelling, warmth, infection, or tissue breakdown require prompt medical assessment. Reduced sensation can allow an injury to become serious without causing significant pain.

Hypoglycemia: A Major Treatment Risk

Hypoglycemia generally refers to glucose below 70 mg/dL, although symptoms and treatment needs vary. It is especially common with insulin and medicines that stimulate insulin release.

Possible symptoms include:

shaking;
sweating;
hunger;
dizziness;
confusion;
weakness;
irritability;
difficulty speaking.

Severe hypoglycemia may cause seizure, unconsciousness, injury, or death. People at risk should have an individualized treatment plan, and close contacts may need to know how and when to use glucagon.

The CDC describes the “15-15 rule” as one common approach for an alert person with glucose below 70 mg/dL: consume 15 grams of rapidly absorbed carbohydrate, wait 15 minutes, and recheck. Individual instructions may differ, particularly for young children or people unable to swallow safely. Severe symptoms require emergency assistance.

Frequent low readings should trigger a treatment review rather than simply repeated self-treatment.

Hyperglycemia, Illness, and Diabetic Ketoacidosis

High glucose can result from insufficient medication, illness, stress hormones, dehydration, certain drugs, or problems with insulin delivery.

Diabetic ketoacidosis develops when the body has too little effective insulin and begins producing dangerous levels of ketones. It is most common in type 1 diabetes but can also occur in type 2 diabetes. Warning signs may include excessive thirst, frequent urination, nausea, abdominal pain, deep or difficult breathing, fruity-smelling breath, severe fatigue, confusion, or fainting.

DKA is a medical emergency. People at risk should receive written sick-day instructions explaining glucose and ketone testing, hydration, medication use, and when to contact a clinician or seek emergency care. Illness plans should be created in advance rather than improvised during an emergency.

Mental Health and Treatment Burden

Diabetes management can be demanding. Monitoring, planning meals, taking medication, managing cost, and worrying about complications can contribute to diabetes distress, anxiety, burnout, or depression.

These difficulties may affect medication use and glucose management. They should not be interpreted as a lack of discipline.

The CDC recommends including emotional support in diabetes care, while NIDDK advises discussing persistent stress, sadness, anger, or anxiety with the healthcare team or a mental health professional.

Simplifying a treatment plan, improving access to education, addressing medication cost, or changing technology may sometimes support adherence more effectively than repeatedly giving the same instructions.

Common Misconceptions

“Type 2 diabetes can always be controlled through willpower”

Type 2 diabetes is influenced by genetics, insulin resistance, pancreatic function, age, medications, environment, sleep, food access, and other health conditions. Lifestyle measures are important, but many people also require medication.

“Insulin is only needed in severe or poorly managed diabetes”

Insulin is essential in type 1 diabetes and may be appropriate at many stages of type 2 diabetes. Its use does not prove that someone caused their condition or failed treatment.

“Natural products can replace prescribed treatment”

The FDA warns that illegally marketed supplements and products claiming to cure or replace approved diabetes treatment may contain ineffective, undisclosed, or unsafe ingredients. Stopping prescribed medication in favor of such products can lead to dangerous hyperglycemia or DKA.

“A normal A1C means diabetes has disappeared permanently”

Improved glucose results may reflect effective medication, weight change, or lifestyle support. Some people with type 2 diabetes may enter remission, but recurrence remains possible and continued medical follow-up is important.

“Only glucose matters”

Blood pressure, cholesterol, kidney function, smoking, eye health, foot health, medication safety, and emotional well-being are also central to long-term outcomes.

Practical Questions to Ask a Healthcare Team

Useful questions include:

Which type of diabetes do I have?
What is my individual A1C or glucose target?
Which medicine addresses glucose, and which protects my heart or kidneys?
Can any medication cause hypoglycemia?
What should I do when I am sick or unable to eat?
Do I need a glucose meter, CGM, insulin pen, or pump?
When should I check ketones?
Which eye, kidney, nerve, and foot examinations do I need?
Could another medicine, supplement, or medical condition affect my glucose?
What should I do if treatment is unaffordable?
Which symptoms require urgent or emergency care?

Medication should not be started, stopped, rationed, or adjusted without appropriate guidance. Cost, side effects, treatment complexity, and difficulties following the plan should be discussed openly.

Future Outlook

Diabetes care is moving toward more individualized treatment and greater integration of glucose, cardiovascular, kidney, weight, and quality-of-life goals.

Likely areas of continued development include:

smaller and longer-lasting glucose sensors;
more accessible automated insulin-delivery systems;
improved prediction of hypoglycemia;
medications with combined glucose, weight, heart, and kidney benefits;
remote education and monitoring;
cell replacement and immune-based therapies for type 1 diabetes;
better identification of diabetes subtypes;
less burdensome insulin formulations.

Technology and new medication can improve care, but access remains uneven. Cost, insurance, device availability, reliable refrigeration, healthcare staffing, and education continue to determine whether effective treatment reaches the people who need it.

Long-term progress will depend not only on developing new treatments but also on making proven care affordable, understandable, and sustainable.

Mixed FAQ

Can diabetes be cured?

Type 1 diabetes currently requires lifelong insulin in nearly all cases. Some people with type 2 diabetes can enter remission, but ongoing monitoring remains important because glucose may rise again.

Does everyone with type 2 diabetes need medication?

No. Some people initially manage glucose through lifestyle changes, while others require medication at diagnosis. Treatment depends on glucose levels, symptoms, complications, and overall risk.

Is metformin always the first treatment?

It remains a common first medication, but current treatment increasingly considers cardiovascular disease, kidney disease, heart failure, obesity, hypoglycemia risk, cost, and individual goals.

Is continuous glucose monitoring better than fingerstick testing?

CGM provides trends and alerts that a single fingerstick cannot provide. A meter may still be needed in certain situations, and not every person requires continuous monitoring.

Can people with diabetes eat carbohydrates?

Yes. Carbohydrates affect glucose, but complete avoidance is generally unnecessary and may not be nutritionally appropriate. Amount, type, timing, and medication coordination are more important.

When is diabetes an emergency?

Severe hypoglycemia, unconsciousness, seizure, signs of DKA, severe dehydration, persistent vomiting, breathing difficulty, or confusion require urgent medical attention.

How often should treatment be reviewed?

Treatment should be reviewed regularly and whenever glucose remains outside the target range, hypoglycemia occurs, complications develop, pregnancy is planned, kidney function changes, or the treatment becomes difficult to follow.

Sources